Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378050%3A_____%2F01%3A23010351" target="_blank" >RIV/68378050:_____/01:23010351 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases.
Original language description
Moderately immunogenic, MHC class I and II negative murine carcinoma MK16 developed after s.c. injection lung metastases, the number and size of lung metastases increased with the increasing size of s. c. tumours. Local cytokine treatment of 5-days MK16tumours and SMRTD with recombinant IL-2 or IL-12 resulted in inhibition of their lung metastases.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EB - Genetics and molecular biology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2001
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Clinical and Experimental Metastasis
ISSN
0262-0898
e-ISSN
—
Volume of the periodical
18
Issue of the periodical within the volume
7
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
7
Pages from-to
581-587
UT code for WoS article
—
EID of the result in the Scopus database
—